Skip to main content
. 2020 Dec 1;39(4):179–186. doi: 10.36185/2532-1900-020

Figure 3.

Figure 3.

Clinical variability in 48 steroid-naïve Duchenne muscular dystrophy boys, age 4 to < 7 years. Shown is Time to Stand velocity (1/event) in DMD boys enrolled into vamorolone clinical trials. Extensive variability in disease severity is seen, with a 6-fold difference in velocity from the most severe to the mildest patient (from Dang et al., 2020 and Smith et al., 2020, mod.) 38,39.